Robert E Topper, MD | |
9970 Central Park Blvd N, 102, Boca Raton, FL 33428-2231 | |
(561) 483-4300 | |
(561) 483-2296 |
Full Name | Robert E Topper |
---|---|
Gender | Male |
Speciality | General Surgery |
Experience | 40 Years |
Location | 9970 Central Park Blvd N, Boca Raton, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1265414510 | NPI | - | NPPES |
P1044535 | Other | FL | OXFORD HEALTH PLAN |
371555800 | Medicaid | FL | |
F29835 | Other | FL | UPIN |
0163205 | Other | FL | GHI |
18180 | Other | FL | BLUE CROSS BLUE SHIELD |
3044ASOS | Other | FL | NHP |
101112 | Other | FL | AVMED |
200513 | Other | FL | AMERIGROUP |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | ME62885 (Florida) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
South Florida Surgical Specialists Llc | 5799881660 | 83 |
News Archive
The researchers from Brigham and Women's Hospital this week have come up with a new study which shows that reducing the inflammation among patients who have already had a heart attack before could prevent the risk of getting more cardiovascular events. The study is published in the latest issue of the New England Journal of Medicine.
Drug repositioning- taking known drugs and identifying new applications for them-is an attractive concept for speeding up the process of bringing drugs to human testing for unmet medical needs.
The University of Navarra, together with the University of Oxford and three other European centres, are taking part in a project to discover the origin of myelodysplasia, an ailment with a predisposition to develop into leukaemia. In the work, patients from 19 hospitals in the north of Spain - including the University Hospital of Navarra - were analysed, as well as from England, Italy, Sweden and Germany.
Global nanotechnology company pSivida Limited, is pleased to announce that its UK operating subsidiary pSiMedica Limited has been granted a new Australian patent for BioSiliconTM.
CureVac GmbH, a clinical stage biopharmaceutical company developing a new class of therapies and vaccines based on mRNA, and the German Federal Research Institute for Animal Health, Friedrich-Loeffler-Institute (FLI), Germany, today announced that mRNA vaccines (RNActive) based on the company's RNA technology platform have the potential to provide effective protection against infectious diseases.
› Verified 8 days ago
Entity Name | South Florida Surgical Specialists Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1952409963 PECOS PAC ID: 5799881660 Enrollment ID: O20070509000683 |
News Archive
The researchers from Brigham and Women's Hospital this week have come up with a new study which shows that reducing the inflammation among patients who have already had a heart attack before could prevent the risk of getting more cardiovascular events. The study is published in the latest issue of the New England Journal of Medicine.
Drug repositioning- taking known drugs and identifying new applications for them-is an attractive concept for speeding up the process of bringing drugs to human testing for unmet medical needs.
The University of Navarra, together with the University of Oxford and three other European centres, are taking part in a project to discover the origin of myelodysplasia, an ailment with a predisposition to develop into leukaemia. In the work, patients from 19 hospitals in the north of Spain - including the University Hospital of Navarra - were analysed, as well as from England, Italy, Sweden and Germany.
Global nanotechnology company pSivida Limited, is pleased to announce that its UK operating subsidiary pSiMedica Limited has been granted a new Australian patent for BioSiliconTM.
CureVac GmbH, a clinical stage biopharmaceutical company developing a new class of therapies and vaccines based on mRNA, and the German Federal Research Institute for Animal Health, Friedrich-Loeffler-Institute (FLI), Germany, today announced that mRNA vaccines (RNActive) based on the company's RNA technology platform have the potential to provide effective protection against infectious diseases.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Robert E Topper, MD 9970 Central Park Blvd N, 102, Boca Raton, FL 33428-2231 Ph: (561) 483-4300 | Robert E Topper, MD 9970 Central Park Blvd N, 102, Boca Raton, FL 33428-2231 Ph: (561) 483-4300 |
News Archive
The researchers from Brigham and Women's Hospital this week have come up with a new study which shows that reducing the inflammation among patients who have already had a heart attack before could prevent the risk of getting more cardiovascular events. The study is published in the latest issue of the New England Journal of Medicine.
Drug repositioning- taking known drugs and identifying new applications for them-is an attractive concept for speeding up the process of bringing drugs to human testing for unmet medical needs.
The University of Navarra, together with the University of Oxford and three other European centres, are taking part in a project to discover the origin of myelodysplasia, an ailment with a predisposition to develop into leukaemia. In the work, patients from 19 hospitals in the north of Spain - including the University Hospital of Navarra - were analysed, as well as from England, Italy, Sweden and Germany.
Global nanotechnology company pSivida Limited, is pleased to announce that its UK operating subsidiary pSiMedica Limited has been granted a new Australian patent for BioSiliconTM.
CureVac GmbH, a clinical stage biopharmaceutical company developing a new class of therapies and vaccines based on mRNA, and the German Federal Research Institute for Animal Health, Friedrich-Loeffler-Institute (FLI), Germany, today announced that mRNA vaccines (RNActive) based on the company's RNA technology platform have the potential to provide effective protection against infectious diseases.
› Verified 8 days ago
Dr. Ehsan Esmaeili, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1905 Clint Moore Rd., Suite 105, Boca Raton, FL 33496 Phone: 561-241-4758 Fax: 561-998-4246 | |
Dr. Lawrence Howard Brickman, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 777 Glades Rd, Boca Raton, FL 33431 Phone: 561-297-4336 Fax: 561-297-4334 | |
Dr. Erica R Podolsky, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1601 Clint Moore Rd, Suite 145, Boca Raton, FL 33487 Phone: 561-939-0455 Fax: 561-939-5460 | |
Michael Dedwylder, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 800 Meadows Rd, Boca Raton, FL 33486 Phone: 561-955-3665 | |
Daniel Kushner, MD Surgery Medicare: Medicare Enrolled Practice Location: 800 Meadows Rd, Boca Raton, FL 33486 Phone: 561-955-3665 | |
Dr. Renzo Cutolo, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 800 Meadows Rd, Boca Raton, FL 33486 Phone: 561-955-7100 | |
Dr. Kerry-ann Camille Alecia Mcdonald, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 690 Meadows Rd, Boca Raton, FL 33486 Phone: 561-955-2131 |